{"schema_version":"secwatch.filing_event.v1","accession":"0001764046-25-000010","form_type":"8-K","ticker":"CLVT","cik":"0001764046","company_name":"CLARIVATE PLC","filed_at":"2025-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.780817+00:00","generated_at":"2026-05-26T12:20:13.135360+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Clarivate Q4 revenue $663M (-3% YoY), adj. EPS $0.21; initiates strategic alternatives review","bullets":["Full year 2024 revenue $2.56B (-2.7% YoY); net loss -$636.7M improved from -$911.2M.","Adjusted EBITDA full year $1.06B vs $1.12B prior; free cash flow $357.5M, down 28.7%.","Repurchased $200M shares and pre-paid $198M debt in 2024; new $500M buyback authorization for 2025-26.","Initiated review of strategic alternatives including potential divestitures; Morgan Stanley and Moelis advising.","Provides 2025 outlook with focus on subscription and re-occurring revenue growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001764046-25-000010","json":"https://secwatch.observer/filing/0001764046-25-000010.json","markdown":"https://secwatch.observer/filing/0001764046-25-000010.md","text":"https://secwatch.observer/filing/0001764046-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764046/000176404625000010/0001764046-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764046/000176404625000010/clvt-20250219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T12:20:13.135360+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}